Related references
Note: Only part of the references are listed.Novel necroptosis-related gene signature for predicting the prognosis of pancreatic adenocarcinoma
Zixuan Wu et al.
Aging-US (2022)
Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer
Zaoqu Liu et al.
NATURE COMMUNICATIONS (2022)
Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease
Wenli Zhao et al.
ACS CHEMICAL NEUROSCIENCE (2022)
Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update
Larissa A. Korde et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
lncRNA lnc-POP1-1 upregulated by VN1R5 promotes cisplatin resistance in head and neck squamous cell carcinoma through interaction with MCM5
Yingying Jiang et al.
MOLECULAR THERAPY (2022)
Bulk and single-cell transcriptome profiling reveal necroptosis-based molecular classification, tumor microenvironment infiltration characterization, and prognosis prediction in colorectal cancer
Wenqin Luo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-κB pathway
Huaili Jiang et al.
CELL DEATH & DISEASE (2022)
Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma
Zhanzhan Li et al.
CANCER MEDICINE (2022)
Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature
Guang-Li Zhu et al.
CANCER MEDICINE (2022)
A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
Junliang Chen et al.
CANCER MEDICINE (2022)
A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer
Xin Zhang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2022)
A Novel Inflammatory Response-Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma
Yanxun Han et al.
FRONTIERS IN GENETICS (2022)
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic Potential
Giovanni Luca Beretta et al.
CELLS (2022)
Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
Chunguang Guo et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Necroptosis and Viral Myocarditis: Tumor Necrosis Factor α as a Novel Biomarker for the Diagnosis of Viral Myocarditis
Jin Zhou et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma
Yilong Lu et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
Multi-Omics Approaches Identify Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Cervical Cancer
JuanMei Zhan et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2022)
Prognosis and personalized treatment prediction in TP53-mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
Chen Yang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer
Zaoqu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
DNA Methylation and HPV-Associated Head and Neck Cancer
Takuya Nakagawa et al.
MICROORGANISMS (2021)
Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
Zaoqu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures
Dongqiang Zeng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer
Leyre Zubiri et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Inhibition of kras-derived exosomes downregulates immunosuppressive BACH2/GATA-3 expression via RIP-3 dependent necroptosis and miR-146/miR-210 modulation
Savvas Petanidis et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
Linlin Ma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Machine-Learning-Based Prediction of Treatment Outcomes Using MR Imaging-Derived Quantitative Tumor Information in Patients with Sinonasal Squamous Cell Carcinomas: A Preliminary Study
Noriyuki Fujima et al.
CANCERS (2019)
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Hyunchul Jung et al.
NATURE COMMUNICATIONS (2019)
Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NE-κB pathway activation through RPS3
Zixian Huang et al.
CELL DEATH & DISEASE (2019)
Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer
Carolina Moretto Carnielli et al.
NATURE COMMUNICATIONS (2018)
Clonal dynamics in osteosarcoma defined by RGB marking
Stefano Gambera et al.
NATURE COMMUNICATIONS (2018)
Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians
Michael Allgaeuer et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth
Jin-Zhou Huang et al.
MOLECULAR CELL (2017)
Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein
Laura A. Laviolette et al.
NATURE COMMUNICATIONS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers et al.
GENOME MEDICINE (2017)
Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer
Fuquan Zhang et al.
CANCER BIOLOGY & THERAPY (2017)
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
D. S. Matassa et al.
CELL DEATH AND DIFFERENTIATION (2016)
The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
Ji-Yeon Kim et al.
SCIENTIFIC REPORTS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Agnieszka K. Witkiewicz et al.
NATURE COMMUNICATIONS (2015)
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
S. S. Chauhan et al.
ONCOGENESIS (2015)
A SIGNIFICANCE TEST FOR THE LASSO
Richard Lockhart et al.
ANNALS OF STATISTICS (2014)
Simultaneous discovery of rare and common segment variants
X. Jessie Jeng et al.
BIOMETRIKA (2013)
Gene set enrichment analysis: performance evaluation and usage guidelines
Jui-Hung Hung et al.
BRIEFINGS IN BIOINFORMATICS (2012)
Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
Ahmed O. Kaseb et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)